Clinical trial
Prospective, Non-interventional Observation Study for the Use of Palivizumab in High-risk Children in Germany- SYNAGIS
NCT01155193 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Non-interventional Observation Study for the Use of Palivizumab in High-risk Children in Germany- SYNAGIS
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 1, 2002
- Completion date
- July 31, 2016
- Enrollment
- 30,804 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.